Pacer Advisors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-59,189
| Closed | -$1.56M | – | 3369 |
|
|
2022
Q3 | $1.56M | Buy |
+59,189
| New | +$1.56M | 0.01% | 449 |
|
|
2022
Q1 | – | Sell |
-25,979
| Closed | -$1.32M | – | 2599 |
|
|
2021
Q4 | $1.32M | Buy |
+25,979
| New | +$1.32M | 0.01% | 1036 |
|
|
2021
Q3 | – | Sell |
-25,434
| Closed | -$1.09M | – | 1464 |
|
|
2021
Q2 | $1.09M | Buy |
25,434
+12,792
| +101% | +$548K | 0.02% | 810 |
|
|
2021
Q1 | $528K | Buy |
12,642
+11,626
| +1,144% | +$486K | 0.01% | 1033 |
|
|
2020
Q4 | $47K | Buy |
1,016
+132
| +15% | +$6.11K | ﹤0.01% | 1422 |
|
|
2020
Q3 | $38K | Buy |
+884
| New | +$38K | ﹤0.01% | 1316 |
|
|
2020
Q2 | – | Sell |
-1,669
| Closed | -$87K | – | 1004 |
|
|
2020
Q1 | $87K | Sell |
1,669
-4,040
| -71% | -$211K | ﹤0.01% | 500 |
|
|
2019
Q4 | $343K | Sell |
5,709
-709
| -11% | -$42.6K | 0.02% | 861 |
|
|
2019
Q3 | $363K | Buy |
6,418
+1,010
| +19% | +$57.1K | 0.01% | 1050 |
|
|
2019
Q2 | $301K | Buy |
5,408
+857
| +19% | +$47.7K | 0.01% | 1028 |
|
|
2019
Q1 | $230K | Buy |
+4,551
| New | +$230K | 0.01% | 637 |
|
|
2018
Q4 | – | Sell |
-2,382
| Closed | -$165K | – | 1081 |
|
|
2018
Q3 | $165K | Buy |
2,382
+1,517
| +175% | +$105K | 0.01% | 1048 |
|
|
2018
Q2 | $65K | Buy |
865
+503
| +139% | +$37.8K | ﹤0.01% | 1095 |
|
|
2018
Q1 | $19K | Sell |
362
-1,082
| -75% | -$56.8K | ﹤0.01% | 1018 |
|
|
2017
Q4 | $77K | Buy |
1,444
+947
| +191% | +$50.5K | 0.01% | 981 |
|
|
2017
Q3 | $30K | Buy |
+497
| New | +$30K | ﹤0.01% | 1140 |
|